Cargando…

Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection

OBJECTIVE: Compare outcomes of patients receiving high-dose oral beta-lactam versus standard oral therapy for Enterobacterales bacteremia from a urinary tract infection (UTI). DESIGN: Retrospective, multicenter, observational cohort. SETTING: Three Michigan community teaching hospitals. PATIENTS: Ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geyer, Abigail C., VanLangen, Kali M., Jameson, Andrew P., Dumkow, Lisa E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523554/ https://www.ncbi.nlm.nih.gov/pubmed/37771747 http://dx.doi.org/10.1017/ash.2023.435

Ejemplares similares

189. Outcomes of High-dose Oral Beta-lactam Step-down Therapy Compared to Alternative Oral Therapy for Bacteremic Urinary Tract Infections
por: Geyer, Abigail, et al.
Publicado: (2023)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
por: Sutton, Jesse D., et al.
Publicado: (2020)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection
por: Elajouz, Balsam, et al.
Publicado: (2022)

Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis
por: Fabre, Valeria, et al.
Publicado: (2014)

1592. Safety of Oral Trimethoprim/Sulfamethoxazole Prophylaxis in Renal Transplant Recipients
por: Horvat, Courtney, et al.
Publicado: (2018)

Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections
por: Worden, Lacy J, et al.
Publicado: (2021)

Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020)

2273. Outcomes of Trimethoprim/Sulfamethoxazole as Definitive Therapy for Urinary Tract Infections with Multi-Drug-Resistant Enterobacteriaceae
por: Adhi, Fatima, et al.
Publicado: (2019)

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial
por: Chetchotisakd, Ploenchan, et al.
Publicado: (2014)

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)

Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone
por: Chan, J. C., et al.
Publicado: (2019)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia
por: Koshy, Robin, et al.
Publicado: (2019)

Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
por: Nayak, Seema U., et al.
Publicado: (2013)

Life-Threatening Thrombocytopenia Secondary to Trimethoprim/Sulfamethoxazole
por: Gaudel, Pramod, et al.
Publicado: (2017)

Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
por: Long, Clara Y, et al.
Publicado: (2021)

Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
por: Bjork, Lauren, et al.
Publicado: (2023)

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis
por: Xu, Xiaonan, et al.
Publicado: (2022)

Osteomyelitis due to methicillin-resistant Staphylococcus aureus successfully treated by an oral combination of minocycline and trimethoprim–sulfamethoxazole
por: Sato, Kojiro, et al.
Publicado: (2019)

Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
por: Al-Jasser, Asma Marzouq
Publicado: (2006)

Fixed Drug Eruption of the Penis Secondary to Sulfamethoxazole-Trimethoprim
por: Lawrentschuk, Nathan, et al.
Publicado: (2006)

A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
por: Hamid, Mohsin, et al.
Publicado: (2018)

Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole
por: Minato, Yusuke, et al.
Publicado: (2018)

Intravitreal Trimethoprim and Sulfamethoxazole Toxicity to the Retina of Albino Rabbits
por: Mazza, Orit, et al.
Publicado: (2018)

Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole
por: Lei, Haibo, et al.
Publicado: (2022)

The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
por: Sato, Takumi, et al.
Publicado: (2022)

Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH
por: Marak, Creticus, et al.
Publicado: (2022)

Trimethoprim-sulfamethoxazole induced aseptic meningitis case report
por: Pata, Giulia, et al.
Publicado: (2023)

277. Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated Enterobacterales Blood Stream Infections
por: Ngo, Nichol, et al.
Publicado: (2020)

Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome
por: Cho, Hyun Jeong, et al.
Publicado: (2013)

Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
por: Deconinck, Laurene, et al.
Publicado: (2019)

Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases
por: Masson, Rahul, et al.
Publicado: (2023)

Trimethoprim sulfamethoxazole drug resistance with co resistance to extended spectrum β-lactam antibiotics among bacterial isolates from HIV patients
por: Rameshkumar, Marimuthu Ragavan, et al.
Publicado: (2014)

Sulfamethoxazole/Trimethoprim induced liver failure: a case report
por: Abusin, Salaheldin, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_psl4irvmv5fmv8vpqk54lt3936